Denise De Belder

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Escherichia Coli

Venous Thromboembolism

Immune Response

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Adriana Efron, Alessia Biolchi, Cecilia Sorhouet Pereira, Sara Tomei, Josefina Campos, Denise De Belder, María Alicia Moscoloni, Mauricio Santos, Gabriela Vidal, Florencia Nocita, Carla Vizzotti, Mariagrazia Pizza
Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB). Human vaccines & immunotherapeutics 19 (3) (2023)
Adriana Efron, Alessia Biolchi, Cecilia Sorhouet Pereira, Sara Tomei, Josefina Campos, Denise De Belder, María Alicia Moscoloni, Mauricio Santos, Gabriela Vidal, Florencia Nocita, Carla Vizzotti, Mariagrazia Pizza
Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB). Human vaccines & immunotherapeutics 19 (3) (2023)
Adriana Efron, Alessia Biolchi, Cecilia Sorhouet Pereira, Sara Tomei, Josefina Campos, Denise De Belder, María Alicia Moscoloni, Mauricio Santos, Gabriela Vidal, Florencia Nocita, Carla Vizzotti, Mariagrazia Pizza
Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB). Human vaccines & immunotherapeutics 19 (3) (2023)
Adriana Efron, Alessia Biolchi, Cecilia Sorhouet Pereira, Sara Tomei, Josefina Campos, Denise De Belder, María Alicia Moscoloni, Mauricio Santos, Gabriela Vidal, Florencia Nocita, Carla Vizzotti, Mariagrazia Pizza
Bactericidal killing of meningococcal W strains isolated in Argentina by the sera of adolescents and infants immunized with 4-component meningococcal serogroup B vaccine (4CMenB). Human vaccines & immunotherapeutics 19 (3) (2023)